{"id":"https://openalex.org/W4414916396","doi":"https://doi.org/10.5603/ocp.107786","title":"Long-term therapeutic response in gallbladder cancer \u2014 the potential of chemoimmunotherapy","display_name":"Long-term therapeutic response in gallbladder cancer \u2014 the potential of chemoimmunotherapy","publication_year":2025,"publication_date":"2025-10-07","ids":{"openalex":"https://openalex.org/W4414916396","doi":"https://doi.org/10.5603/ocp.107786"},"language":"en","primary_location":{"id":"doi:10.5603/ocp.107786","doi":"https://doi.org/10.5603/ocp.107786","is_oa":true,"landing_page_url":"https://doi.org/10.5603/ocp.107786","pdf_url":"https://journals.viamedica.pl/oncology_in_clinical_practice/article/download/107786/85097","source":{"id":"https://openalex.org/S2737348819","display_name":"Oncology in Clinical Practice","issn_l":"2450-1654","issn":["2450-1654","2450-6478"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology in Clinical Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://journals.viamedica.pl/oncology_in_clinical_practice/article/download/107786/85097","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004340758","display_name":"Marta Pabianek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Pabianek","raw_affiliation_strings":["Chemotherapy Unit and One-Day Chemotherapy Unit, Specialist Oncology Hospital NU-MED, Tomaszow Mazowiecki, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Unit and One-Day Chemotherapy Unit, Specialist Oncology Hospital NU-MED, Tomaszow Mazowiecki, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Magdalena Sobocinska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Magdalena Sobocinska","raw_affiliation_strings":["Chemotherapy Unit and One-Day Chemotherapy Unit, Specialist Oncology Hospital NU-MED, Tomaszow Mazowiecki, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Unit and One-Day Chemotherapy Unit, Specialist Oncology Hospital NU-MED, Tomaszow Mazowiecki, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082406659","display_name":"Barbara \u0141ochowska","orcid":"https://orcid.org/0000-0002-5115-5497","observed_orcids":["https://orcid.org/0000-0002-5115-5497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Lochowska","raw_affiliation_strings":["Chemotherapy Unit and One-Day Chemotherapy Unit, Specialist Oncology Hospital NU-MED, Tomaszow Mazowiecki, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Unit and One-Day Chemotherapy Unit, Specialist Oncology Hospital NU-MED, Tomaszow Mazowiecki, Poland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018456614","display_name":"Magdalena A. Ci\u0105\u017cy\u0144ska","orcid":"https://orcid.org/0000-0002-9709-3383","observed_orcids":["https://orcid.org/0000-0002-9709-3383"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Magdalena A. Ci\u0105\u017cy\u0144ska","raw_affiliation_strings":["Chemotherapy Unit and One-Day Chemotherapy Unit, Specialist Oncology Hospital NU-MED, Tomaszow Mazowiecki, Poland;\r\nDepartment of Dermatology, Paediatric Dermatology and Oncology Clinic, Medical University of Lodz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Unit and One-Day Chemotherapy Unit, Specialist Oncology Hospital NU-MED, Tomaszow Mazowiecki, Poland;\r\nDepartment of Dermatology, Paediatric Dermatology and Oncology Clinic, Medical University of Lodz, Poland","institution_ids":["https://openalex.org/I4210122071"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36345591,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"0","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10518","display_name":"Gallbladder and Bile Duct Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gallbladder-cancer","display_name":"gallbladder cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8059999942779541},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/biliary-tract-adenocarcinoma","display_name":"biliary tract adenocarcinoma","score":0.9490000009536743},{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":0.9409999847412109},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9190000295639038},{"id":"https://openalex.org/keywords/expanded-access-program","display_name":"expanded access program","score":0.6990000009536743},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9624000191688538},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.9186000227928162},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.8130000233650208},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.71670001745224},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6323999762535095},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5972999930381775},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5644999742507935},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.506600022315979},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48669999837875366},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41119998693466187},{"id":"https://openalex.org/C2777148285","wikidata":"https://www.wikidata.org/wiki/Q64386","display_name":"Gallbladder","level":2,"score":0.4092000126838684},{"id":"https://openalex.org/C2776534502","wikidata":"https://www.wikidata.org/wiki/Q977787","display_name":"Gallbladder cancer","level":3,"score":0.4020000100135803},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3837999999523163},{"id":"https://openalex.org/C2775982439","wikidata":"https://www.wikidata.org/wiki/Q3562150","display_name":"Biliary tract","level":2,"score":0.37130001187324524},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3594000041484833},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.31869998574256897},{"id":"https://openalex.org/C2778424827","wikidata":"https://www.wikidata.org/wiki/Q5090613","display_name":"Chemoradiotherapy","level":3,"score":0.31690001487731934},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.28850001096725464},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.27559998631477356},{"id":"https://openalex.org/C133507102","wikidata":"https://www.wikidata.org/wiki/Q4712977","display_name":"Genitourinary system","level":2,"score":0.26600000262260437},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2653000056743622},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.26350000500679016},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.25540000200271606},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.25459998846054077}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5603/ocp.107786","doi":"https://doi.org/10.5603/ocp.107786","is_oa":true,"landing_page_url":"https://doi.org/10.5603/ocp.107786","pdf_url":"https://journals.viamedica.pl/oncology_in_clinical_practice/article/download/107786/85097","source":{"id":"https://openalex.org/S2737348819","display_name":"Oncology in Clinical Practice","issn_l":"2450-1654","issn":["2450-1654","2450-6478"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology in Clinical Practice","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:be585d56dddf43609137f491b9320853","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/be585d56dddf43609137f491b9320853","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Oncology in Clinical Practice, Vol 22, Iss Continuous Publishing (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.5603/ocp.107786","doi":"https://doi.org/10.5603/ocp.107786","is_oa":true,"landing_page_url":"https://doi.org/10.5603/ocp.107786","pdf_url":"https://journals.viamedica.pl/oncology_in_clinical_practice/article/download/107786/85097","source":{"id":"https://openalex.org/S2737348819","display_name":"Oncology in Clinical Practice","issn_l":"2450-1654","issn":["2450-1654","2450-6478"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology in Clinical Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320323344","display_name":"Uniwersytet \u0141\u00f3dzki","ror":"https://ror.org/05cq64r17"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414916396.pdf","grobid_xml":"https://content.openalex.org/works/W4414916396.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Malignant":[0],"biliary":[1,102,239],"tract":[2,103,240],"tumors,":[3],"including":[4],"gallbladder":[5],"cancer":[6],"and":[7,21,76,87,126,150,195,212,226,253],"cholangiocarcinoma,":[8],"are":[9,113],"associated":[10],"with":[11,19,31,45,53,74,99,108,111,155,233,237],"particularly":[12],"poor":[13],"prognoses.":[14],"For":[15],"many":[16,168],"years,":[17],"chemotherapy":[18,109],"cisplatin":[20,75],"gemcitabine":[22],"was":[23,118,148,206],"the":[24,32,38,46,61,64,94,130,175,179,185,223],"only":[25],"available":[26,92],"treatment":[27,79,117,171,190,243],"option":[28],"for":[29,191,250],"patients":[30,98,236],"advanced":[33,101,238],"disease.":[34],"A":[35],"breakthrough":[36],"in":[37,51,72,178,197,209,235,245,258],"management":[39],"of":[40,48,63,97,157,170,202,217,230,256],"this":[41,246],"patient":[42,186],"group":[43],"came":[44],"introduction":[47],"immunotherapy,":[49],"especially":[50],"com\u00adbination":[52],"chemotherapy.":[54],"The":[55,116],"TOPAZ-1":[56],"clinical":[57,199],"trial":[58],"demonstrated":[59],"that":[60],"use":[62],"programmed":[65],"death-ligand":[66],"1":[67],"(PD-L1)":[68],"checkpoint":[69],"inhibitor":[70],"durvalumab,":[71],"combination":[73],"gemcitabine,":[77],"improves":[78],"efficacy,":[80],"significantly":[81,173],"prolonging":[82],"both":[83,210],"overall":[84],"survival":[85,89],"(OS)":[86],"progression-free":[88,218],"(PFS).":[90],"Using":[91],"research,":[93],"case":[95],"reports":[96],"unresectable":[100],"adenocarcinoma":[104],"who":[105],"were":[106],"treated":[107],"combined":[110,232],"durvalumab":[112,231],"presented":[114],"herein.":[115],"initiated":[119],"within":[120,129],"an":[121],"Expanded":[122],"Access":[123],"Program":[124,136,138],"(EAP)":[125],"subsequently":[127],"continued":[128],"Polish":[131],"National":[132],"Health":[133],"Fund\u2019s":[134],"Drug":[135],"(":[137],"Lekowy":[139],"Ministerstwa":[140],"Zdrowia":[141],").":[142],"In":[143,182],"selected":[144,259],"patients,":[145],"disease":[146],"stabili\u00adzation":[147],"observed":[149],"a":[151],"long-term":[152],"therapeutic":[153],"response":[154,244],"maintenance":[156],"very":[158],"good":[159,198],"performance":[160],"status":[161],"(Eastern":[162],"Cooperative":[163],"Oncology":[164],"Group":[165],"0)":[166],"over":[167,192],"months":[169,194],"\u2014":[172],"exceeded":[174],"outcomes":[176],"reported":[177],"registration":[180],"trial.":[181],"one":[183],"case,":[184],"had":[187],"been":[188],"receiving":[189],"30":[193],"remains":[196],"condition":[200],"(as":[201],"July":[203],"2025).":[204],"Treatment":[205],"well":[207],"tolerated":[208],"cases":[211],"led":[213],"to":[214],"substantial":[215],"prolongation":[216],"survival.":[219],"These":[220],"findings":[221],"illustrate":[222],"high":[224],"efficacy":[225],"acceptable":[227],"safety":[228],"profile":[229],"che\u00admotherapy":[234],"cancers.":[241],"Long-term":[242],"population":[247],"gives":[248],"hope":[249],"better":[251],"prognosis":[252],"improved":[254],"quality":[255],"life":[257],"cases.":[260]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}